Search
Search
About
Log in
Join
Experiences with
Rybrevant
Posts
Communities
1 public post
Filter results
Two new drug approvals (for patients with EGFR Exon 20 insertion and patients with KRAS G12C mutation)
The FDA based their approval on the results of the clinical trial CHRYSALIS which showed that patients receiving
Rybrevant
responded to the drug for a year. In addition to approving
Rybrevant
, the FDA also granted approval for Guardant360 CDx as a companion diagnostic.
The FDA based their approval on the results of the clinical trial CHRYSALIS which showed that patients receiving
Rybrevant
responded to the drug for a year. In addition to approving
Rybrevant
, the FDA also granted approval for Guardant360 CDx as a companion diagnostic.
Miranda_GO2
Partner
in
Lung Cancer Support
3 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Filter results
Clear filters
Posted in
All communities
Lung Cancer Support
1 result
Sort by
Most Relevant
Newest